Testicular Tumors Flashcards
testicular tumors - epidemiology
*most common tumor of young men
*one of the most curable of all cancers
*no clear etiology, but 10% have history of undescended testis
*bilateral in 2-3%
*>50% of patients present with metastatic disease
*“right goes left, but left stays left” (nodal spread)
*distant mets via blood to lung, liver, brain, bones, kidney
*10% present with epididymitis
testicular malignancies - classifications
-
germ cell tumors
a. seminoma
b. non seminomas (embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma) - non-germ cell tumors
a. sex cord stromal tumors (sertoli cell tumors, leydig cell tumors)
b. secondary malignancies (lymphoma, metastases)
general considerations of testicular tumors
*typically present as a firm, painless mass (therefore, CANNOT BE TRANSILLUMINATED on physical exam)
*do NOT biopsy (risk of seeding the scrotum)
*typical age of incidence: 15-40 years
*general risk factors:
-cryptorchidism
-Klinefelter syndrome
-Down syndrome
-testicular dysgenesis syndrome
tumor marker: alpha fetoprotein (AFP)
*elevated in 50-70% of non-seminoma germ cell tumors (NSGCT)
*produced by embryonal carcinoma and yolk sac tumors
*NOT produced in pure choriocarcinoma or seminoma
*half-life of 4-6 days
tumor marker: human chorionic gonadotropin (hCG)
*elevated in all choriocarcinomas
*elevated in 40-60% of embryonal carcinoma
*elevated in 5-10% of seminomas
*half-life of 24 hrs
tumor marker: lactase dehydrogenase (LDH)
*non-specific tumor marker
*elevated in about half of the cases of testicular tumors
*attests to tumor burden
seminoma - overview
*most common germ cell testicular tumor
*originates in the germinal epithelium of the seminiferous tubules
*75% are confined to testis at presentation; 15% involve regional nodes; 10% with distant spread
seminoma - gross pathologic features
*well-demarcated, homogenous, pale mass
*no hemorrhage
*no necrosis
seminoma - microscopic pathologic features
*large cells, clear cytoplasm, central nuclei (“fried egg” appearance)
*placental alkaline phosphatase (PLAP) positive in up to 98% of seminomas
seminoma - 3 types
- classic seminoma (85%)
- anaplastic seminoma (10%) - more aggressive with higher metastatic potential
- spermatocytic seminoma (5%) - classically seen in OLDER patients
seminoma - clinical presentation
*painless testicular mass (some may present with testicular discomfort or swelling)
*mass CANNOT be transilluminated
*relatively slow growing
*mean age at presentation = 40 years
*6-10x higher incidence among white men
*increased PLAP
seminoma - tumor markers
*hCG produced in 5-10% of seminomas
*NO pure seminoma produces AFP
*increased placental alkaline phosphatase (PLAP)
seminoma - therapy considerations
*do NOT perform a biopsy
*discuss sperm banking
*radical inguinal orchiectomy (removal of testicle; confirms diagnosis & helps determine staging)
*management depends on stage
*good prognosis
*does respond to radiation therapy
embryonal carcinoma testicular tumor - overview
*a non-seminoma germ cell testicular cancer
embryonal cell testicular tumor - gross pathologic features
*hemorrhagic mass with necrosis
*usually smaller than seminomas (i.e. does not replace the entire testis)
embryonal cell testicular tumor - microscopic pathologic features
*immature, primitive cells (“embryo-like”) with prominent nucleoli and pleomorphic nuclei
*resemble undifferentiated stem cells
*may form glands
embryonal cell testicular tumor - clinical presentation
*painless testicular mass
*early hematogenous spread: retroperitoneum, lung, liver
*typically positive for placental alkaline phosphatase (PLAP)
embryonal cell testicular tumor - tumor markers
*may secrete alpha fetoprotein (AFP) or beta-hCG, but usually BOTH
embryonal cell testicular tumor - therapy considerations
*do NOT biopsy
*discuss sperm banking
*chemotherapy may lead to differentiation of tumor cell types (resulting in a new, more mature tumor type)